Iran (IMNA) - With the capability to produce 70 different types of radiopharmaceuticals, Iran now serves over 6,500 nuclear medicine centers, solidifying its position as a global leader in this field.
Early cancer detection remains one of the most challenging aspects of combating the disease. During the initial stages of tumor development, tissues appear normal, while significant changes at the cellular metabolism level go undetected by conventional diagnostic methods such as ultrasound and radiography, which focus only on tissue shape and size.
In this context, nuclear imaging technologies, particularly nuclear medicine, play a crucial role. These techniques involve injecting a small amount of radioactive substance (radioisotope) into the body, enabling imaging devices to observe cellular activity with high precision. This approach allows for the early detection of tumors and the identification of hidden metastases far earlier than conventional methods like Magnetic Resonance Imaging (MRI) or CT scans.
Beyond diagnostics, nuclear technology also provides innovative treatment solutions. Unlike traditional radiotherapy, which delivers radiation externally and may damage healthy surrounding tissues, nuclear medicine offers more targeted therapies, enhancing treatment efficacy while minimizing harmful side effects.
Your Comment